Platelet Changes While on ECMO Support
Part of Heart & circulation, Lungs & breathing clinical trials.
This study looks at how blood cells called platelets change in people who are on a heart-lung machine (ECMO) in the ICU. It aims to better understand how the body responds to this support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are being treated in an intensive care unit at Strasbourg University Hospital.
- You have been connected to a heart-lung machine (ECMO—either for heart or lung support) within the last 24 hours.
- You have not said you do not want to be in the study.
- You are not under any legal protection, guardianship, or curatorship.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of using a heart-lung machine (ECMO) during lung transplant surgery. The goal is to see if using ECMO only when needed works as well as using it for everyone. This could help reduce risks and improve recovery.
This study looks at inflammation during ECMO (a heart-lung bypass machine) and while people are being weaned off it. It may help doctors better understand which patients are improving safely during ECMO and when to reduce support.
This study examines how blood clotting cells (platelets) behave when patients are on a heart-lung support machine called ECMO. Researchers will take small blood samples to understand if the machine affects platelet function and how to manage blood thinning medication safely.
This trial is studying the blood biomarkers and platelet characteristics in patients who receive CPR and are then placed on a heart-lung bypass machine (ECPR). It aims to understand how these biological markers relate to patient outcomes.
This study looks at ways to improve breathing and blood flow in patients who are on a heart-lung machine (ECMO) for severe heart problems. It may help doctors better manage care for people in intensive care.
This study tracks bleeding, clotting problems, and blood transfusion needs in ICU patients with COVID-19 who are on a special heart-lung machine called V-V ECMO. It helps doctors understand how to better care for these very ill patients.
Hear when a new Cardiac Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.